EFFECTS OF GRAFT VS HOST REACTIONS ON CELL-MEDIATED IMMUNITY
移植物抗宿主反应对细胞介导免疫的影响
基本信息
- 批准号:3813460
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:CD4 molecule CD8 molecule MHC class I antigen T cell receptor T lymphocyte autoantibody biomarker cell components cell mediated lymphocytolysis test colony stimulating factor complement cytolysis cytotoxic T lymphocyte graft versus host disease helper T lymphocyte hematopoietic stem cells hypogammaglobulinemia immunosuppression interleukin 3 laboratory mouse systemic lupus erythematosus thymus
项目摘要
The long-term effects of parent-into-F1 graft-versus-host reaction (GVHR)
was investigated by following splenic T cell markers and function for up to
18 months after GVHR induction. Despite the appearance of adequate numbers
of T cells which expressed the normal compliment of T lymphocyte markers,
these cells still failed to generate MHC self-restricted, CD4-mediated T
helper responses. This defect was not due to suppression or a defect in
antigen-presenting cell function. Analysis of donor chimerism in
parent-into-F1 GVHR indicated three phases of repopulation: an expansion
phase of donor T cells; a phase of host cell destruction; and a donor
repopulation phase in which extensive donor cell repopulation is observed.
Donor T cells that induce GVHR were studied for T cell receptor repertoire
by Vbeta analyses. It was observed that donor T cell expressing the Vbeta
markers of antihost reactivity were selectively expanded during GVHR. Vbeta
analysis was also used to investigate the possible synergy between class I
GVHR and donor-antihost m1s recognition. It was found that donor-antihost
recognition of class I H-2 and m1s(a) resulted in acute GVHR, and
preferential expansion of the Vbeta T cell receptor reactive with m1s(a).
Depletion of these Vbeta T cells resulted in reduced donor chimerism, but
not in abrogation of GVH-induced immune deficiency.
父级 - into-f1移植物与宿主反应(GVHR)的长期影响
通过遵循脾T细胞标记和功能来研究
GVHR诱导后18个月。尽管有足够的数字
表达T淋巴细胞标记正常称赞的T细胞,
这些细胞仍然无法生成MHC自限制的CD4介导的T
助手响应。该缺陷不是由于抑制或缺陷
抗原呈递细胞功能。分析供体嵌合体
parent-Into-f1 GVHR指示了三个阶段的重生阶段:扩展
供体T细胞的相;宿主细胞破坏的阶段;和捐助者
观察到广泛的供体细胞再捕集的重生阶段。
研究了诱导GVHR的供体T细胞用于T细胞受体库
通过VBETA分析。观察到表达VBETA的供体T细胞
在GVHR期间,选择性扩大了抗抑制反应性的标记。 vbeta
分析还用于研究I类可能的协同作用
GVHR和捐助者antihost M1识别。发现捐助者 - 抗thihost
识别I类H-2和M1S(A)导致急性GVHR,并且
VBETA T细胞受体与M1s的优先扩展(a)。
这些vbeta T细胞的耗竭导致供体嵌合体减少,但
没有废除GVH诱导的免疫缺陷。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
G M SHEARER其他文献
G M SHEARER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('G M SHEARER', 18)}}的其他基金
CELL MEDIATED IMMUNITY TO HAPTEN MODIFIED SYNGENEIC LYMPHOCYTES IN MICE
小鼠中针对半抗原修饰的同源淋巴细胞的细胞介导的免疫
- 批准号:
4691755 - 财政年份:
- 资助金额:
-- - 项目类别:
DETECTION AND ANALYSIS OF H-2 VARIANT CELL LINES FROM MURINE T CELL LYMPHOMAS
鼠 T 细胞淋巴瘤 H-2 变异细胞系的检测和分析
- 批准号:
4691769 - 财政年份:
- 资助金额:
-- - 项目类别:
SYNERGISTIC EFFECTS OF MURINE CYTOMEGALOVIRUS AND GRAFT-VERSUS-HOST REACTION
鼠巨细胞病毒与移植物抗宿主反应的协同效应
- 批准号:
3962949 - 财政年份:
- 资助金额:
-- - 项目类别:
IMMUNE STUDIES IN HOMOSEXUAL MEN AT RISK FOR ACQUIRED IMMUNE DEFICIENCY SYNDROME
对有获得性免疫缺陷综合症风险的男同性恋者进行免疫研究
- 批准号:
3939243 - 财政年份:
- 资助金额:
-- - 项目类别:
SYNERGISTIC EFFECTS OF MURINE CYTOMEGALOVIRUS AND GRAFT-VERSUS-HOST REACTION
鼠巨细胞病毒与移植物抗宿主反应的协同效应
- 批准号:
3916407 - 财政年份:
- 资助金额:
-- - 项目类别:
REGULATION OF HUMAN T CELL RESPONSES BY ADHERENT CELLS
贴壁细胞对人类 T 细胞反应的调节
- 批准号:
3939372 - 财政年份:
- 资助金额:
-- - 项目类别:
相似海外基金
Novel cell therapy approaches for molecularly defined subsets of therapy-resistant melanoma
针对分子定义的难治性黑色素瘤子集的新型细胞治疗方法
- 批准号:
10780289 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Novel Biologics Designed to Mobilize HIV-specific CTL for Sustained HIV Remission
旨在调动 HIV 特异性 CTL 以实现持续 HIV 缓解的新型生物制剂
- 批准号:
9752177 - 财政年份:2019
- 资助金额:
-- - 项目类别:
Novel Biologics Designed to Mobilize HIV-specific CTL for Sustained HIV Remission
旨在调动 HIV 特异性 CTL 以实现持续 HIV 缓解的新型生物制剂
- 批准号:
9908044 - 财政年份:2019
- 资助金额:
-- - 项目类别:
Novel Biologics Designed to Mobilize HIV-specific CTL for Sustained HIV Remission
旨在调动 HIV 特异性 CTL 以实现持续 HIV 缓解的新型生物制剂
- 批准号:
10375382 - 财政年份:2019
- 资助金额:
-- - 项目类别:
Pre-clinical testing of a novel immunotherapy for HTLV-induced neurologic disease
针对 HTLV 诱发的神经系统疾病的新型免疫疗法的临床前测试
- 批准号:
10055787 - 财政年份:2016
- 资助金额:
-- - 项目类别: